ORBIMED ADVISORS LLC 13D and 13G filings for TELA Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-25 4:24 pm Sale | 2024-10-23 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 1,182,717 4.800% | -941,550 (-44.32%) | Filing |
| 2024-10-01 5:35 pm Sale | 2024-09-27 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,124,267 8.600% | -313,700 (-12.87%) | Filing |
| 2024-07-02 4:58 pm Sale | 2024-06-28 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,437,967 9.900% | -428,300 (-14.94%) | Filing |
| 2023-04-21 5:03 pm Sale | 2023-04-19 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,866,267 11.900% | -192,000 (-6.28%) | Filing |
| 2022-08-19 4:17 pm Unchanged | 2022-08-18 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 3,058,267 16.500% | 0 (Unchanged) | Filing |